Instrumental variable and colocalization analyses identify endotrophin and HTRA1 as potential therapeutic targets for coronary artery disease
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Neurological Disorders and Stroke (12/21/22)
- National Institutes of Health (T32GM007200, F30HL162576, P01HL151328, T32HL134635, UM1HG008853, F30HL152521, R01HL159171)
- National Cancer Institute
- National Institute on Drug Abuse
- National Heart, Lung, and Blood Institute
- Foundation for Barnes-Jewish Hospital
- Novo Nordisk
- National Institute of Mental Health
- National Human Genome Research Institute
This publication has 92 references indexed in Scilit:
- Adipocyte-derived endotrophin promotes malignant tumor progressionJournal of Clinical Investigation, 2012
- Effect of a Monoclonal Antibody to PCSK9 on LDL CholesterolNew England Journal of Medicine, 2012
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysisThe Lancet, 2012
- Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspectsCell and tissue research, 2011
- LocusZoom: regional visualization of genome-wide association scan resultsBioinformatics, 2010
- Association of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel DiseaseNew England Journal of Medicine, 2009
- Binding of Proprotein Convertase Subtilisin/Kexin Type 9 to Epidermal Growth Factor-like Repeat A of Low Density Lipoprotein Receptor Decreases Receptor Recycling and Increases DegradationJournal of Biological Chemistry, 2007
- An integrative genomics approach to infer causal associations between gene expression and diseaseNature Genetics, 2005
- Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9Nature Genetics, 2005
- HtrA1 serine protease inhibits signaling mediated by Tgfβ family proteinsDevelopment, 2004